
Photo: INS Vikrant and INS Vikramaditya, Indian Navy, GODL-India
UPSC Civil Services (Main) 2019 · GS Paper III
UPSC Mains 2019 GS 3 · Q15: model answer
General Studies Paper III: Technology, Economic Development, Bio-diversity, Environment, Security and Disaster Management · Science and Technology.
How is the Government of India protecting traditional knowledge of medicine from patenting by pharmaceutical companies?
Syllabus: Science and Technology · IPR and indigenisation of technology
Traditional knowledgeBiopiracyTKDLDisclosure of origin
India's traditional knowledge (TK) of medicine, in Ayurveda, Unani, Siddha, Sowa Rigpa and Yoga, has been recorded for centuries. Because it is in the public domain, it can be misappropriated through patents on minor variations, a practice called biopiracy. A US patent on turmeric for healing wounds (1995, revoked in 1997 after CSIR's challenge) and a European patent on a neem-based fungicide (1994, revoked in 2000) exposed the threat. India now relies on defensive protection, domestic law and global diplomacy.
1. Defensive protection through TKDL
- What it is: the Traditional Knowledge Digital Library (TKDL), set up in 2001 by CSIR and the Ministry of Ayush, converts formulations from classical texts into a searchable database in five languages: English, French, German, Japanese and Spanish.
- How it works: patent offices such as the European Patent Office use it as prior art, and India files evidence against wrongful applications.
- Defensive, not proprietary: TKDL gives India no patent; it stops others from getting one.
2. Safeguards in Indian law
- Patents Act, 1970 (as amended): Section 3(p) says that TK, or an aggregation or duplication of known properties of traditional components, is not an invention; applicants must disclose the source and origin of biological material, and a patent can be opposed for non-disclosure or for being anticipated by knowledge, oral or written, of local or indigenous communities (Section 25).
- Biological Diversity Act, 2002: IP based on Indian biological resources or associated knowledge needs the National Biodiversity Authority's approval, with benefit-sharing; People's Biodiversity Registers document local knowledge. The 2023 amendment eased compliance for Ayush practitioners but kept NBA approval for such IP.
- Benefit-sharing model: the Kani tribe of Kerala received a share of licence fees for "Jeevani", a drug developed by the Tropical Botanic Garden and Research Institute from their knowledge of the arogyapacha plant.
3. International efforts
- Disclosure of origin: India has long demanded that patent applicants disclose the origin of genetic resources and TK and show prior informed consent and benefit-sharing, in line with the Convention on Biological Diversity and the Nagoya Protocol (2010).
- WIPO Treaty on IP, Genetic Resources and Associated Traditional Knowledge (24 May 2024): makes such disclosure mandatory; India pushed for it but had not ratified it, and with only four parties by mid-2026 it was not yet in force.
- Global standing: the WHO Global Centre for Traditional Medicine at Jamnagar (2022) supports evidence and standards.
| Layer | Instrument | What it does |
|---|---|---|
| Defensive database | TKDL (2001) | Prior art for patent examiners |
| Patent law | Patents Act, Sections 3(p) and 25 | Excludes TK; allows opposition |
| Biodiversity law | Biological Diversity Act, 2002; NBA | Prior approval and benefit-sharing |
| International | Nagoya Protocol; WIPO treaty (2024) | Disclosure of origin |
4. Gaps
- Oral knowledge: tribal and folk knowledge outside classical texts is poorly documented, and TKDL covers mainly codified systems.
- Enforcement: monitoring patent filings worldwide is costly, and benefit-sharing with communities remains weak.
India has moved from fighting individual cases to a systemic defence of its heritage. Documenting oral knowledge with communities, ratifying the WIPO treaty and enforcing benefit-sharing can protect traditional medicine while letting it serve global health.
The ₹149 All-in-One Pass opens the rest of the site for 12 months: UPSC Prelims GS Paper I and CSAT with explanations, practice quizzes and timed tests, UPSC CAPF and EPFO, the previous papers of every APPSC, TSPSC, police and SSC exam, every mock test series and the study books.
₹149 · valid for 12 months from the day you pay, on every exam · pay by UPI, card or net banking